Africa will be hardest hit region of anti-microbial resistance, warns report

11 December 2014
africa-malaria

Low income countries are likely to suffer the greatest loss of population and economic output if anti-microbial resistance (AMR) continues to spread unchecked, according to a KPMG report.

The report, commissioned by the independent Review on Antimicrobial Resistance, established by the UK Prime Minister in the summer and chaired by economist Jim O’Neill, aims to quantify some of the consequences of higher AMR levels by looking at the impact different AMR scenarios could have on the economies of 156 countries by 2050.

The hardest hit region is projected to be Africa, with a worst case scenario predicting a fall in GDP of $2.9 trillion in 2050, which represents 20% of the region’s total economic output.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical